Roser Solans Laque Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca Email Roser Solans Laque Email Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca
Research lines Genetic bases of Behçet disease. We are currently enrolled in this multicentre study to investigate the possible influence of the genetic background in the disease pathogenesis, and to try to establish links between genetic variations and different clinical and biological patterns. The research is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute by sending samples from our cohort of patients along with the clinical data, and reviewing the results. It is supported by a SAS grant. IP: Roser Solans Laque Development and validation of a consensus of a systemic disease activity index for primary Sjögren’s syndrome. EULAR Sjögren’s Task Force. We are currently enrolled in this multicentre study supported by the “EULAR Sjögren’s Task Force” to elaborate and agree on a systemic disease activity index for patients with primary Sjögren’s syndrome, that will be useful in the management of the disease. This study is coordinated by Dr. Raphaele Seror from the “Service de Rheumatologie Hôpital Bicêtre”, France. IP: Roser Solans Laque Spanish Registry of patients with primary Sjögren’s syndrome. This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). Its main goal consist in investigate the factors involved in extraglandular development in our country. This study is coordinated by Dr. Manel Ramos from the Clinic Hospital, Barcelona. IP: Roser Solans Laque Spanish Registry of patients with Behçet disease (REGEB). This is a multicentre study supported by the Systemic Autoimmune Diseases Group from the Spanish Internal Medicine Society. The aim of the study is to describe the different clinical forms of disease presentation in our country and the response of the disease to conventional treatment. IP: Roser Solans Laque Pagination Current page 1 Page 2 Page 3 Next page › Last page » Projects Ajuts Grups de Recerca (SGR) 2022 IP: Jaume Alijotas Reig Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Ajuts Grups de Recerca (SGR) 2022, Ariadna Anunciacion Llunell Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00048 Duration: 01/01/2022 - 30/06/2025 Autoimmunitat i Malaltia Trombòtica (GRC) IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: Reference: 2014 SGR 329 Duration: 01/01/2014 - 31/12/2016 Estudio clínico e inmunológico de la afección cardíaca en fase de remisión clínica de la Poliangeítis con Granulomatosis eosinofílica IP: Roser Solans Laque Collaborators: - Funding agency: Mutual Mèdica de Catalunya i Balears Funding: 4000 Reference: 2014\BMM\SOLANS Duration: 27/11/2014 - 26/11/2015 Determinación del riesgo de afectación extraglandular y desarrollo de linfoma en el Síndrome de Sjögren primario mediante estudio de poblaciones linfocitarias y citocinas en sangre y tejido IP: Roser Solans Laque Collaborators: Carlos Palacio García, Margarita Alberola Ferranti, Fernando Martínez Valle Funding agency: Instituto de Salud Carlos III Funding: 35695 Reference: PI13/00655 Duration: 01/01/2014 - 30/06/2018 Pagination Current page 1 Page 2 Next page › Last page »
